Please login to the form below
Sapient
This page shows the latest Sapient news and features for those working in and with pharma, biotech and healthcare.
Publicis Groupe to acquire Sapient for $3.7bn
Publicis Groupe to acquire Sapient for $3.7bn. Merger comes just months after Publicis’ failed acquisition of Omnicom. ... The acquisition will create a new unit within Publicis Groupe that will go under the name Publicis.Sapient.
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Business Unit Head, Medical Communications, London
-
Excellent package
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Senior Project Manager - Medical Writing
-
Great salary and bebefits
- Multi-Channel Account Managers - Road / Homebased – Full or Part...
-
Competitive salary
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
Subscribe to our email news alerts
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- NHS England says yes to Roche's Hemlibra
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Moving annual total (MAT)
- Vertex to Theresa May: Orkambi verdict ‘threatens bio investment’
- Roche keeps Venclexta train rolling with new leukaemia filing
- Shift to preventative healthcare - Opportunities for screening, diagnostics and vaccination
- Conference Live for ongoing congress performance measurement
- Eyeforpharma Real World Evidence Conference Round up 2018
- GDPR and events. What does the pharma industry need to know?
- Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use
- ‘Common Rulebook’ Brexit plans include medicines – but face backlash
PMHub
Anthill Agency
Anthill is a specialist digital agency and a strategic partner for life science companies....
Latest intelligence
- GDPR and events. What does the pharma industry need to know?
- ...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
- The rise of vertical integration in the US payer landscape
- Is it a solution to addressing the challenges of the value-based marketplace?...
Quick links
Infographics
